Navigation Links
Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications
Date:7/31/2014

NORTHBROOK, Ill., July 31, 2014 /PRNewswire/ -- Astellas has appointed Moyra Knight as the head of corporate and employee communications in the Americas region. Knight will report directly to Jeff Winton, senior vice president, chief communications officer. In this role, Knight will be responsible for developing and leading corporate brand initiatives and reputation management to achieve Astellas' strategic business goals across North and South America. She will also lead corporate social responsibility, executive communications, employee and digital communication and corporate media relations. 

"I am thrilled to add someone with Moyra's reputation and proven track record to the new and growing communications team at Astellas," said Winton. "Moyra's breadth of experience along with her approach to leadership will help accelerate Astellas' brand awareness."

Knight's appointment is the latest phase in the building of the new Corporate Communications team that was launched at Astellas in late 2013 with the appointment of Jeff Winton. Winton came to Astellas from Eli Lilly and Company where he was the Vice President/Head, Global Communications and member of Global Corporate Affairs Leadership Team.

Knight has more than 20 years of communications experience in both the health care and consumer industries. Most recently, she worked at Baxter International Inc. where she held various senior positions within corporate communications. Prior to that, Knight worked at Ogilvy Public Relations Worldwide and Kraft Foods, Inc. where she led various teams focused on consumer marketing, communications, and public affairs. Knight received her undergraduate degree in journalism from the University of Colorado at Boulder.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health
'/>"/>

SOURCE Astellas
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
2. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
3. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
5. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
6. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
7. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
8. Astellas to Drive PGA TOURs New Womens Initiative
9. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
10. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
11. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... KONG , August 28, 2015 ... in collaboration with one of the leading academics in ... (current world record holder in life extension for model ... insights into biology of aging and age-related diseases, primarily, around ... The work has just been published as "Stability analysis of ...
(Date:8/28/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... OTC brands from GSK in an all cash transaction ... demonstration of Perrigo,s unique ability to maximize brand value ... countries.  Perrigo Chairman, President and CEO ... to complete this transaction, which clearly demonstrates our ability ...
(Date:8/28/2015)... 28, 2015 , Joint research by ... from Biostar , Published in ,Stem Cells Translational ... lifespan through multiple IV administration of Adipose-derived MSC ... expectancy found , Commercialization within 5 years expected ... possibility that adult mesenchymal stem cells (MSCs) may extend ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... 12 Novartis Pharma AG has entered into an agreement ... (iloperidone), a new oral medication that is approved by the ... of adults with schizophrenia. Novartis plans to launch Fanapt ... part of the agreement with Vanda Pharmaceuticals Inc., Novartis will ...
... Conn., Oct. 12 VION PHARMACEUTICALS, INC. (OTC ... investment banking firm Merriman Curhan Ford & Co. to assist ... of a restructuring of the Company and its debt and ... may also consider financing options. , As previously reported, the ...
Cached Medicine Technology:Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 8Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 2Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 3
(Date:8/28/2015)... Columbus, Ohio (PRWEB) , ... August 28, 2015 ... ... Saturday’s Imagine No Malaria Day at the Zoo to celebrate children helping children, ... people and their congregations throughout West Ohio have contributed to the United Methodist ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Medical Devices:, Understanding the FDA’s Position and Best Practices for Compliance, **Presented ... , This workshop, chaired by internationally renowned expert Fubin Wu, has ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... of high grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine ... a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... of the Veterans Award, honoring military veterans leading in business. Mr. Troy ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize ...
(Date:8/28/2015)... ... , ... Northridge dentists Dr. Elyson and Dr. Assili are now ... currently receive a one hour treatment of this teeth whitening option. Zoom whitening ... of unique features that can turn teeth up to nine shades whiter. Effective on ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... CMP India and CMP Information,The Netherlands, is once ... Conference on Food Ingredients in Mumbai on,October 3-4th, 2008. ... Fi Events,held in Europe, Asia, Latin America and Africa., ... took place in Mumbai in September 2006 for the ...
... provide the most effective treatments for cancer patients, it ... early detection of the disease. A team of ... has developed a system which aims to pinpoint potential ... this by looking at the structures of specific sugar ...
... Today, Congresswoman,Stephanie Tubbs Jones applauded the Senate passage ... by a veto-proof margin of 69 to,30. She ... my Senate colleagues passed bipartisan legislation,that will ensure ... doctors,by eliminating the physician pay cut, as well ...
... 9 A lawsuit charges,pharmaceutical giant Pfizer was ... public of potentially deadly side-effects associated with its ... the trade name,Chantix. The suit, brought by the ... suicide after using Chantix as prescribed. The victim,s,tragic ...
... may point to new targets for treatment, study says , , ... to one family,s hereditary form of atrial fibrillation may help ... heart rhythm problem, according to a new report. , ... was discovered by Mayo Clinic researchers studying a large family ...
... and CEO of the American,Association for Homecare, ... and providers are just as appalled as lawmakers ... used identification,numbers from deceased doctors to bilk millions ... providers and manufacturers represented by,the American Association for ...
Cached Medicine News:Health News:CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients 2Health News:A short and sweet diagnosis for cancer? 2Health News:Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris 2Health News:Gene Mutation Tied to Inherited Atrial Fibrillation 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 3
The Auto Suture™ SIGNET™ staplers place one staple each time the instrument handles are squeezed. The staples first penetrate the skin and are then formed, thus holding the tissue togethe...
The Auto Suture DFS stapler is a disposable fascia stapler. The stapler places one staple each time the instrument handles are activated. The staples first penetrate the fascia and are then formed, t...
... PROXIMATE RH skin stapler is a ... head assembly., ,PROXIMATE RH has improved ... along with a ratchet mechanism for easier ... a sterile, single patient use instrument designed ...
... two staggered rows of titanium staples in 30mm, ... up to three times for a maximum of ... for thick tissue. The TLV model fires vascular ... , Parallel jaw closure ensures that tissue is ...
Medicine Products: